UROGEN PHARMA LTD's ticker is URGN and the CUSIP is M96088105. A total of 66 filers reported holding UROGEN PHARMA LTD in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $5,688 | -91.2% | 406 | -93.5% | 0.00% | – |
Q2 2023 | $64,418 | -87.3% | 6,224 | -88.7% | 0.00% | – |
Q1 2023 | $507,368 | +4.7% | 54,910 | +0.5% | 0.00% | – |
Q4 2022 | $484,435 | +16047.8% | 54,615 | +16400.0% | 0.00% | – |
Q3 2022 | $3,000 | -50.0% | 331 | -55.3% | 0.00% | – |
Q2 2022 | $6,000 | -45.5% | 741 | -39.6% | 0.00% | – |
Q1 2022 | $11,000 | -79.2% | 1,227 | -78.1% | 0.00% | – |
Q4 2021 | $53,000 | -8.6% | 5,612 | +63.0% | 0.00% | – |
Q3 2021 | $58,000 | +65.7% | 3,443 | +49.4% | 0.00% | – |
Q2 2021 | $35,000 | +2.9% | 2,305 | +33.2% | 0.00% | – |
Q1 2021 | $34,000 | -57.5% | 1,731 | -60.9% | 0.00% | – |
Q4 2020 | $80,000 | +86.0% | 4,426 | +96.4% | 0.00% | – |
Q3 2020 | $43,000 | -76.5% | 2,253 | -67.8% | 0.00% | – |
Q2 2020 | $183,000 | +51.2% | 7,004 | +3.6% | 0.00% | – |
Q1 2020 | $121,000 | -32.8% | 6,759 | +25.6% | 0.00% | – |
Q4 2019 | $180,000 | +414.3% | 5,383 | +258.4% | 0.00% | – |
Q3 2019 | $35,000 | -83.0% | 1,502 | -73.8% | 0.00% | – |
Q2 2019 | $206,000 | +1772.7% | 5,732 | +1761.0% | 0.00% | – |
Q1 2019 | $11,000 | – | 308 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
GREAT POINT PARTNERS LLC | 2,620,545 | $36,713,835 | 6.69% |
Wildcat Capital Management, LLC | 495,606 | $6,943,440 | 2.79% |
SILVERARC CAPITAL MANAGEMENT, LLC | 508,883 | $7,129,451 | 2.16% |
Opaleye Management Inc. | 320,000 | $4,483,200 | 1.46% |
AlphaCentric Advisors LLC | 165,000 | $2,311,650 | 1.31% |
Soleus Capital Management, L.P. | 372,000 | $5,211,720 | 0.48% |
EAM Investors, LLC | 170,523 | $2,389,027 | 0.46% |
RA Capital Management | 1,483,697 | $20,786,595 | 0.41% |
Parkman Healthcare Partners LLC | 145,311 | $2,035,807 | 0.37% |
MENORA MIVTACHIM HOLDINGS LTD. | 2,303,031 | $32,265,464 | 0.29% |